Literature DB >> 15564347

Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables.

Kati Thieme1, Dennis C Turk, Herta Flor.   

Abstract

OBJECTIVE: The prevalence as well as predictors of psychiatric disorders (Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] axis I and II) in patients with fibromyalgia syndrome (FMS) was evaluated.
METHOD: One-hundred fifteen patients with FMS participated in the Structured Clinical Interview for DSM-IV to assess current mental disorders. In addition, patients completed standardized questionnaires regarding pain, pain impact, anxiety, depression, posttraumatic stress disorder-like symptoms, and sexual and physical abuse.
RESULTS: Patients were grouped into one of three psychosocial subgroups based on responses to the Multidimensional Pain Inventory (MPI)-Dysfunctional (DYS), Interpersonally Distressed (ID), and Adaptive Copers (AC). Axis I diagnoses were present in 74.8% of the participants overall with the DYS subgroup mainly reporting anxiety and the ID group mood disorders. The AC group showed little comorbidity. Axis II diagnoses were present in only 8.7% of the FMS sample.
CONCLUSION: These results suggest that FMS is not a homogeneous diagnosis, but shows varying proportions of comorbid anxiety and depression dependent on psychosocial characteristics of the patients. The results demonstrate the importance of not treating patients with FMS as a homogeneous group. Assessment should not only examine the presence of widespread pain and the number of tender points, but also the presence of affective distress. Treatment should focus both on physical and emotional dysfunction.

Entities:  

Mesh:

Year:  2004        PMID: 15564347     DOI: 10.1097/01.psy.0000146329.63158.40

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  105 in total

Review 1.  Deconstructing chronic low back pain in the older adult--Step by step evidence and expert-based recommendations for evaluation and treatment part III: Fibromyalgia syndrome.

Authors:  Gita Fatemi; Meika A Fang; Paula Breuer; Paul E Cherniak; Angela Gentili; Joseph T Hanlon; Jordan F Karp; Natalia E Morone; Eric Rodriguez; Michelle I Rossi; Kenneth Schmader; Debra K Weiner
Journal:  Pain Med       Date:  2015-08-14       Impact factor: 3.750

2.  [Comorbid depression mediates the association of childhood/adolescent maltreatment and fibromyalgia syndrome. A study with patients from different clinical settings].

Authors:  M Kosseva; S Schild; R Wilhelm-Schwenk; W Biewer; W Häuser
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

3.  Advancing the screening of fibromyalgia in late-life depression: practical implications for psychiatric settings.

Authors:  John R Jochum; Amy E Begley; Mary Amanda Dew; Debra K Weiner; Jordan F Karp
Journal:  Int Psychogeriatr       Date:  2015-04-24       Impact factor: 3.878

4.  Correlates of perceived pain-related restrictions among women with fibromyalgia.

Authors:  Peter Przekop; Mark G Haviland; Kelly R Morton; Keiji Oda; Gary E Fraser
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

Review 5.  Opioids for managing chronic non-malignant pain: safe and effective prescribing.

Authors:  Meldon Kahan; Anita Srivastava; Lynn Wilson; Angela Mailis-Gagnon; Deana Midmer
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

6.  Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease".

Authors:  Afton L Hassett; Diane C Radvanski; Steven Buyske; Shantal V Savage; Leonard H Sigal
Journal:  Am J Med       Date:  2009-09       Impact factor: 4.965

7.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

8.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

9.  The role of personality in patients with fibromyalgia.

Authors:  Andrew Seto; Xingyi Han; Lori Lyn Price; William F Harvey; Raveendhara R Bannuru; Chenchen Wang
Journal:  Clin Rheumatol       Date:  2018-10-01       Impact factor: 2.980

10.  Biomedical markers and psychiatric morbidity of neurasthenia spectrum disorders in four outpatient clinics in India.

Authors:  V P Paralikar; M M Agashe; S B Sarmukaddam; H N Dabholkar; D Gosoniu; M G Weiss
Journal:  Indian J Psychiatry       Date:  2008-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.